Iain Ross

Insider Reports History

Entity
Individual
Location
C/O Callisto Pharmaceuticals, Inc., 420 Lexington Ave., Suite 1609, New York, NY
Signature
/s/ Rhonda Hellums, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Iain Ross:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Silence Therapeutics plc Director Share Option (Right to Buy) 90K Jan 2, 2025 Direct
Silence Therapeutics plc Director Ordinary Shares 39.9K Jan 2, 2025 Direct

Insider Reports Filed by Iain Ross

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SLN Silence Therapeutics plc Jan 2, 2025 1 $0 4 Jan 6, 2025 Director
SLN Silence Therapeutics plc Jan 2, 2025 0 $0 3 Jan 2, 2025 Director